Treatment and assessment of emergency department nausea and vomiting in Australasia: A survey of anti-emetic management
Objective: To describe the treatment and assessment of emergency department nausea and vomiting (EDNV) in Australasia by Fellows of the Australasian College for Emergency Medicine (FACEM). To determine the influence of various factors on FACEM anti-emetic choice. To compare the influence of drug eff...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
2011
|
| Online Access: | http://hdl.handle.net/20.500.11937/38081 |
| _version_ | 1848755222931832832 |
|---|---|
| author | Mee, M. Egerton-Warburton, Diana Meek, R. |
| author_facet | Mee, M. Egerton-Warburton, Diana Meek, R. |
| author_sort | Mee, M. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Objective: To describe the treatment and assessment of emergency department nausea and vomiting (EDNV) in Australasia by Fellows of the Australasian College for Emergency Medicine (FACEM). To determine the influence of various factors on FACEM anti-emetic choice. To compare the influence of drug effectiveness, side effects, cost and pharmacy directives on adult EDNV anti-emetic choice between FACEM choosing the two most common first-line agents. Methods: A cross-sectional survey of all FACEM practising in Australasian ED was conducted by mail-out in February 2009. Results: Of all FACEM surveyed 48.7% (532/1092) responded. The most common first-line drugs for adult EDNV were metoclopramide (87.3%, 453/519), 5HT3 antagonists (7.9%, 41/519) and prochlorperazine (2.3%, 12/519). For paediatric EDNV, the most common first-line agents were 5HT3 antagonists (86.2%, 307/356), metoclopramide (6.7%, 24/356) and promethazine (5.1%, 18/356). For most FACEM anti-emetic choice was highly influenced by perceived drug efficacy (96.1%) and side effects (82.5%), and 32.9% of FACEM were highly influenced by drug cost. Few FACEM reported ED anti-emetic protocols for adults (13.0%) or children (16.7%) in their ED. FACEM seldom used scales or tools to measure EDNV severity in adult (2.5%) or paediatric (3.4%) patients. Conclusions: Fellows of the Australasian College for Emergency Medicine anti-emetic choice in Australasian ED has been described. The main influences on anti-emetic choice were patient age, perceived drug efficacy and drug side-effect profiles. |
| first_indexed | 2025-11-14T08:52:53Z |
| format | Journal Article |
| id | curtin-20.500.11937-38081 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T08:52:53Z |
| publishDate | 2011 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-380812017-09-13T14:13:04Z Treatment and assessment of emergency department nausea and vomiting in Australasia: A survey of anti-emetic management Mee, M. Egerton-Warburton, Diana Meek, R. Objective: To describe the treatment and assessment of emergency department nausea and vomiting (EDNV) in Australasia by Fellows of the Australasian College for Emergency Medicine (FACEM). To determine the influence of various factors on FACEM anti-emetic choice. To compare the influence of drug effectiveness, side effects, cost and pharmacy directives on adult EDNV anti-emetic choice between FACEM choosing the two most common first-line agents. Methods: A cross-sectional survey of all FACEM practising in Australasian ED was conducted by mail-out in February 2009. Results: Of all FACEM surveyed 48.7% (532/1092) responded. The most common first-line drugs for adult EDNV were metoclopramide (87.3%, 453/519), 5HT3 antagonists (7.9%, 41/519) and prochlorperazine (2.3%, 12/519). For paediatric EDNV, the most common first-line agents were 5HT3 antagonists (86.2%, 307/356), metoclopramide (6.7%, 24/356) and promethazine (5.1%, 18/356). For most FACEM anti-emetic choice was highly influenced by perceived drug efficacy (96.1%) and side effects (82.5%), and 32.9% of FACEM were highly influenced by drug cost. Few FACEM reported ED anti-emetic protocols for adults (13.0%) or children (16.7%) in their ED. FACEM seldom used scales or tools to measure EDNV severity in adult (2.5%) or paediatric (3.4%) patients. Conclusions: Fellows of the Australasian College for Emergency Medicine anti-emetic choice in Australasian ED has been described. The main influences on anti-emetic choice were patient age, perceived drug efficacy and drug side-effect profiles. 2011 Journal Article http://hdl.handle.net/20.500.11937/38081 10.1111/j.1742-6723.2011.01386.x restricted |
| spellingShingle | Mee, M. Egerton-Warburton, Diana Meek, R. Treatment and assessment of emergency department nausea and vomiting in Australasia: A survey of anti-emetic management |
| title | Treatment and assessment of emergency department nausea and vomiting in Australasia: A survey of anti-emetic management |
| title_full | Treatment and assessment of emergency department nausea and vomiting in Australasia: A survey of anti-emetic management |
| title_fullStr | Treatment and assessment of emergency department nausea and vomiting in Australasia: A survey of anti-emetic management |
| title_full_unstemmed | Treatment and assessment of emergency department nausea and vomiting in Australasia: A survey of anti-emetic management |
| title_short | Treatment and assessment of emergency department nausea and vomiting in Australasia: A survey of anti-emetic management |
| title_sort | treatment and assessment of emergency department nausea and vomiting in australasia: a survey of anti-emetic management |
| url | http://hdl.handle.net/20.500.11937/38081 |